JP5787873B2 - インビボイメージング用の放射性標識ピリジニル誘導体 - Google Patents

インビボイメージング用の放射性標識ピリジニル誘導体 Download PDF

Info

Publication number
JP5787873B2
JP5787873B2 JP2012500269A JP2012500269A JP5787873B2 JP 5787873 B2 JP5787873 B2 JP 5787873B2 JP 2012500269 A JP2012500269 A JP 2012500269A JP 2012500269 A JP2012500269 A JP 2012500269A JP 5787873 B2 JP5787873 B2 JP 5787873B2
Authority
JP
Japan
Prior art keywords
contrast agent
vivo
pbr
compound
precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2012500269A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012520855A (ja
JP2012520855A5 (enExample
Inventor
ワズワース、ハリー・ジョン
トリッグ、ウィリアム・ジョン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of JP2012520855A publication Critical patent/JP2012520855A/ja
Publication of JP2012520855A5 publication Critical patent/JP2012520855A5/ja
Application granted granted Critical
Publication of JP5787873B2 publication Critical patent/JP5787873B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2012500269A 2009-03-19 2010-03-19 インビボイメージング用の放射性標識ピリジニル誘導体 Expired - Fee Related JP5787873B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16142509P 2009-03-19 2009-03-19
US61/161,425 2009-03-19
GB0904715.0 2009-03-19
GBGB0904715.0A GB0904715D0 (en) 2009-03-19 2009-03-19 Aryloxyanilide derivataives
PCT/EP2010/053614 WO2010106166A2 (en) 2009-03-19 2010-03-19 Aryloxyanilide derivatives

Publications (3)

Publication Number Publication Date
JP2012520855A JP2012520855A (ja) 2012-09-10
JP2012520855A5 JP2012520855A5 (enExample) 2013-05-02
JP5787873B2 true JP5787873B2 (ja) 2015-09-30

Family

ID=40639799

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012500269A Expired - Fee Related JP5787873B2 (ja) 2009-03-19 2010-03-19 インビボイメージング用の放射性標識ピリジニル誘導体

Country Status (6)

Country Link
US (1) US20120003154A1 (enExample)
EP (1) EP2408451A2 (enExample)
JP (1) JP5787873B2 (enExample)
CN (1) CN102355899B (enExample)
GB (1) GB0904715D0 (enExample)
WO (1) WO2010106166A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0921967D0 (en) * 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel Aryloxyanilide Derivatives
KR101602912B1 (ko) * 2013-09-13 2016-03-11 주식회사 바이오이미징코리아 [18ｆ]플루오르메틸기가 도입된 뇌신경염증 표적 양성자방출단층촬영 방사성추적자, 이의 합성 및 그를 이용한 생물학적 결과 평가 방법
US10940685B2 (en) * 2015-12-28 2021-03-09 The Procter & Gamble Company Method and apparatus for applying a material onto articles using a transfer component that deflects on both sides
EP3452294B1 (en) * 2016-05-06 2023-10-11 Entrust Corporation Label module for printing custom customer engagement labels
CN119409686B (zh) * 2025-01-07 2025-09-05 四川大学华西医院 苯杂氮卓类衍生物、放射性探针及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1004573T3 (da) * 1997-08-04 2003-03-03 Nihon Nohyaku Co Ltd Aryloxyanilinderivater
JP4302207B2 (ja) * 1997-08-04 2009-07-22 大正製薬株式会社 アリールオキシアニリン誘導体
JP2000001476A (ja) * 1998-06-15 2000-01-07 Taisho Pharmaceut Co Ltd アリールオキシ含窒素アリールアミン誘導体
GB0115927D0 (en) 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination
GB0115929D0 (en) 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase electrophilic fluorination
US6870069B2 (en) 2003-01-10 2005-03-22 National Institute Of Radiological Sciences Phenyloxyaniline derivatives
EP1854781A1 (en) 2005-02-28 2007-11-14 Taisho Pharmaceutical Co., Ltd Radioactive halogen-labeled phenyloxyaniline derivatives
WO2007036785A2 (en) 2005-09-29 2007-04-05 Ge Healthcare Limited Carbon-isotope monoxide labeling of daa1106 and its analogues to be used as tracers for a peripheral type benzodiazepine binding site
WO2007074383A1 (en) 2005-12-28 2007-07-05 Ge Healthcare Limited 18f-labeled phenoxyphenyl n-benzyl alkanamid derivatives for positron emission tomography (pet) imaging of peripheral benzodiazepine receptor
WO2010015340A1 (en) * 2008-08-06 2010-02-11 Bayer Schering Pharma Aktiengesellschaft Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment

Also Published As

Publication number Publication date
CN102355899B (zh) 2015-10-07
JP2012520855A (ja) 2012-09-10
CN102355899A (zh) 2012-02-15
US20120003154A1 (en) 2012-01-05
EP2408451A2 (en) 2012-01-25
WO2010106166A3 (en) 2011-03-31
WO2010106166A2 (en) 2010-09-23
GB0904715D0 (en) 2009-05-06

Similar Documents

Publication Publication Date Title
KR20110133492A (ko) Ｐｂｒ 리간드로서의 트리시클릭 인돌 유도체
RU2512288C2 (ru) Производные индола, подходящие для визуализации нейровоспаления
JP5787873B2 (ja) インビボイメージング用の放射性標識ピリジニル誘導体
JP2009515940A (ja) 末梢ベンゾジアゼピンレセプター（ｐｂｒ）親和性を有するインビボイメージング剤としての四環式インドール誘導体
JP2013538818A (ja) 気分障害のインビボイメージング方法
US20120034165A1 (en) Imaging the central nervous system with purinergic p2x7 receptor binding agents
JP2013507345A (ja) インビボイメージング剤としてのフルマゼニルの［１８ｆ］標識類似体
JP5744057B2 (ja) アリールオキシアニリドイメージング剤
EP2247316B1 (en) Imaging the central nervous system

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130314

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130314

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140701

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140930

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150604

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150630

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150728

R150 Certificate of patent or registration of utility model

Ref document number: 5787873

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees